Smith Andrew Alasdair 4
4 · Medicus Pharma Ltd. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Smith Andrew Alasdair
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2025-12-16+50,000→ 50,000 totalExercise: $1.80Exp: 2030-12-16→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year.